Burosumab-twza Subcutaneous and Capozide
Determining the interaction of Burosumab-twza Subcutaneous and Capozide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: captopril / hydrochlorothiazide
Brand name: Capozide 25/15, Capozide 25/25, Capozide 50/15, Capozide 50/25
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Capozide 25/15
- Burosumab-twza Subcutaneous-Capozide 25/25
- Burosumab-twza Subcutaneous-Capozide 50/15
- Burosumab-twza Subcutaneous-Capozide 50/25
- Burosumab-twza Subcutaneous-Caprelsa
- Burosumab-twza Subcutaneous-Capreomycin
- Capozide-Buspar
- Capozide-Buspar Dividose
- Capozide-Buspirone
- Capozide-Buspirone Hydrochloride
- Capozide-Busulfan
- Capozide-Busulfan Concentrate Injection